MorphoSys AG (XTRA:MOR) announced that it has entered into an agreement with new investor Incyte Corporation (NasdaqGS:INCY) for private placement of American Depositary Shares for gross proceeds of $150,000,000 on January 12, 2020. The shares will be issued at a premium to the share price at signing of the agreement. The agreement is subject to clearance by the United States antitrust authorities under the Hart-Scott-Rodino Act as well as by the German and Austrian antitrust authorities, and will become effective as soon as these conditions have been met.

The securities issued in the transaction have a hold period of 18 months.